Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,658 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comprehensive genomic profiling for patients with chemotherapy-naïve advanced cancer.
Kondo T, Matsubara J, Quy PN, Fukuyama K, Nomura M, Funakoshi T, Doi K, Sakamori Y, Yoshioka M, Yokoyama A, Tamaoki M, Kou T, Hirohashi K, Yamada A, Yamamoto Y, Minamiguchi S, Nishigaki M, Yamada T, Kanai M, Matsumoto S, Muto M. Kondo T, et al. Among authors: yoshioka m. Cancer Sci. 2021 Jan;112(1):296-304. doi: 10.1111/cas.14674. Epub 2020 Nov 21. Cancer Sci. 2021. PMID: 33007138 Free PMC article.
Novel 5-fluorouracil-resistant human esophageal squamous cell carcinoma cells with dihydropyrimidine dehydrogenase overexpression.
Kikuchi O, Ohashi S, Nakai Y, Nakagawa S, Matsuoka K, Kobunai T, Takechi T, Amanuma Y, Yoshioka M, Ida T, Yamamoto Y, Okuno Y, Miyamoto S, Nakagawa H, Matsubara K, Chiba T, Muto M. Kikuchi O, et al. Among authors: yoshioka m. Am J Cancer Res. 2015 Jul 15;5(8):2431-40. eCollection 2015. Am J Cancer Res. 2015. PMID: 26396918 Free PMC article.
Qualitative and Quantitative Analysis of Posttreatment Strategy After Endoscopic Resection for Patients with T1 Colorectal Cancer at High Risk of Lymph Node Metastasis.
Nishikawa Y, Horimatsu T, Nishizaki D, Kohno A, Yokoyama A, Yoshioka M, Hida K, Sakanaka K, Minamiguchi S, Seno H, Sakai Y, Nakayama T. Nishikawa Y, et al. Among authors: yoshioka m. J Gastrointest Cancer. 2020 Mar;51(1):242-249. doi: 10.1007/s12029-019-00247-4. J Gastrointest Cancer. 2020. PMID: 31044357
Current status and issues related to secondary findings in the first public insurance covered tumor genomic profiling in Japan: multi-site questionnaire survey.
Minamoto A, Yamada T, Shimada S, Kinoshita I, Aoki Y, Oda K, Ueki A, Higashigawa S, Morikawa M, Sato Y, Hirasawa A, Ogawa M, Kondo T, Yoshioka M, Kanai M, Muto M, Kosugi S. Minamoto A, et al. Among authors: yoshioka m. J Hum Genet. 2022 Oct;67(10):557-563. doi: 10.1038/s10038-022-01028-x. Epub 2022 Mar 23. J Hum Genet. 2022. PMID: 35322199
Inter-assay variability of next-generation sequencing-based gene panels.
Quy PN, Fukuyama K, Kanai M, Kou T, Kondo T, Yoshioka M, Matsubara J, Sakuma T, Minamiguchi S, Matsumoto S, Muto M. Quy PN, et al. Among authors: yoshioka m. BMC Med Genomics. 2022 Apr 15;15(1):86. doi: 10.1186/s12920-022-01230-y. BMC Med Genomics. 2022. PMID: 35428255 Free PMC article.
Prevalence of pathogenic germline variants in the circulating tumor DNA testing.
Yamamoto Y, Fukuyama K, Kanai M, Kondo T, Yoshioka M, Kou T, Quy PN, Kimura-Tsuchiya R, Yamada T, Matsumoto S, Kosugi S, Muto M. Yamamoto Y, et al. Among authors: yoshioka m. Int J Clin Oncol. 2022 Oct;27(10):1554-1561. doi: 10.1007/s10147-022-02220-x. Epub 2022 Jul 23. Int J Clin Oncol. 2022. PMID: 35870019 Free PMC article.
1,658 results